-
Published 7/14/2026
Berumen A, Staron A, Kalaitzidis G, Siddiqi OK, Gopal DM, Ruberg FL, Sanchorawala V. Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era. Blood Adv. 2026 Jul 14; 10(13):4612-4616. PMID: 41995749.
-
Published 6/9/2026
Siddiqi OK, Jahn B, Rochau U, Walukaga S, Rajasingham R, Siebert U. Cost-effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis. Clin Infect Dis. 2026 Jun 09. PMID: 42263199.
-
Published 4/10/2026
Ferri GM, Urina-Jassir M, Stanisic AV, Hensien JM, Lee G, Sullivan N, Siddiqi OK. Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity. Cardiooncology. 2026 Apr 10; 12(1). PMID: 41964070.
-
Published 12/3/2025
Siddiqi HK, Bhatt K, Gopal DM, Siddiqi OK. Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2026 Feb 10; 87(5):502-504. PMID: 41335083.
-
Published 5/27/2025
Siddiqi OK, Ruberg FL, Gopal DM. Impact of Vutrisiran on Functional Capacity and Quality of Life in ATTR Cardiomyopathy: HELIOS-B Analysis. J Am Coll Cardiol. 2025 May 27; 85(20):1956-1958. PMID: 40398974.